Publications by authors named "Aritro Nath"

Claim this Profile
D
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy.
Isaac Bishara, Patrick A Cosgrove, Sumana Majumdar, Colt A Egelston, Oscar Colunga Flores, Aritro Nath

NPJ Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cells.
Eric F Medina, Elena Farmaki, Jason I Griffiths, Andrea H Bild, Aritro Nath

Cell Rep Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer.
Jason I Griffiths, Feng Chi, Elena Farmaki, Eric F Medina, Patrick A Cosgrove, Aritro Nath

Mol Syst Biol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers.
Jason I Griffiths, Patrick A Cosgrove, Eric F Medina, Aritro Nath, Jinfeng Chen

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview.
Pankaj Garg, Gargi Singhal, Siddhika Pareek, Prakash Kulkarni, David Horne, Aritro Nath

Biochim Biophys Acta Rev Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hallmarks of Predictive Oncology.
Akshat Singhal, Xiaoyu Zhao, Patrick Wall, Emily So, Guido Calderini, Aritro Nath

Cancer Discov· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope's Clinical Trial Teams.
Patrick A Cosgrove, Andrea H Bild, Thanh H Dellinger, Behnam Badie, Jana Portnow, Aritro Nath

J Clin Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind.
Rena Emond, Jeffrey West, Vince Grolmusz, Patrick Cosgrove, Aritro Nath

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells.
Feng Chi, Jason I Griffiths, Aritro Nath, Andrea H Bild

Breast Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer.
Elena Farmaki, Aritro Nath, Rena Emond, Kimya L Karimi, Vince K Grolmusz

Elife· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell facilitation promotes growth and survival under drug pressure in breast cancer.
Rena Emond, Jason I Griffiths, Vince Kornél Grolmusz, Aritro Nath, Jinfeng Chen

Nat Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A machine learning framework for scRNA-seq UMI threshold optimization and accurate classification of cell types.
Isaac Bishara, Jinfeng Chen, Jason I Griffiths, Andrea H Bild, Aritro Nath

Front Genet· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting clinical response to everolimus in ER+ breast cancers using machine-learning.
Aritro Nath, Patrick A Cosgrove, Jeffrey T Chang, Andrea H Bild

Front Mol Biosci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling phenotypic plasticity and evolution in small cell lung cancer.
Aritro Nath

Cell Syst· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ENDORSE: a prognostic model for endocrine therapy in estrogen-receptor-positive breast cancers.
Aritro Nath, Adam L Cohen, Andrea H Bild

Mol Syst Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery.
Shunan Liu, Yanyan Song, Ian Y Zhang, Leying Zhang, Hang Gao, Aritro Nath

Neurotherapeutics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Non-Coding RNA as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma.
Adam M Lee, Asmaa Ferdjallah, Elise Moore, Daniel C Kim, Aritro Nath

Int J Mol Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.
Aritro Nath, Patrick A Cosgrove, Hoda Mirsafian, Elizabeth L Christie, Lance Pflieger

Nat Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging Single-Cell Approaches in Cancer Precision Medicine.
Aritro Nath, Andrea H Bild

Trends Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palmitate-Induced IRE1-XBP1-ZEB Signaling Represses Desmoplakin Expression and Promotes Cancer Cell Migration.
Aritro Nath, Amrita Oak, Kevin Y Chen, Irene Li, R Chauncey Splichal

Mol Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer.
Feng Chi, Jiayi Liu, Samuel W Brady, Patrick A Cosgrove, Aritro Nath

Transl Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Peter H O'Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, Julianne P Hall, Aritro Nath

Breast Cancer Res Treat· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model.
Vince Kornél Grolmusz, Jinfeng Chen, Rena Emond, Patrick A Cosgrove, Lance Pflieger, Aritro Nath

Cancer Cell Int· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA targeting energy metabolism in ovarian cancer: a potent contender for future therapeutics.
Siddhika Pareek, Aritro Nath, R Stephanie Huang

Ann Transl Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging role of long non-coding RNAs in cancer precision medicine.
Aritro Nath, R Stephanie Huang

Mol Cell Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis